Project to Demonstrate World's First Printed Programmable Logic Device

Nano ePrint Ltd, the pioneer in planar nano-electronics, announced that it has secured a Grant for Research + Development from the UK's Northwest Regional Development Agency (NWDA). The grant will provide £234k of funding towards a £390k project to demonstrate Nano ePrint's unique printed programmable logic architecture.

This complements other venture investment and grant funding raised by the company to industrialise and commercialise its innovative approach to printed electronics.

Nano ePrint has already demonstrated that its nano-scale devices not only dramatically simplify manufacture, but also achieve over 10 times the performance and over 100 times the density of conventional printed electronics.

This new funding supports the further development of Nano ePrint's modular and configurable circuit architecture to deliver the world's first printed programmable logic devices.

This approach enables low-cost, high-volume manufacture of a generic circuit design, which can then be tailored for customer-specific requirements as it is integrated into downstream printing processes.

Nano ePrint can therefore address a wide range of market applications, from niche novelty products (such as simple printed electronic games) right through to mass-market electronic smart packaging, with a single device.

Scott White, Chief Executive Officer of Nano ePrint, commented: “This exceptional grant highlights the novelty of Nano ePrint's approach and the huge market opportunity enabled by our printed programmable logic architecture. We are grateful for the support of the NWDA in further developing this groundbreaking technology.”

Nano ePrint will be showcasing its technology and product concepts at the IDTechEx Printed Electronics USA conference on December 1st to 4th. The company will be exhibiting at booth number 68, and Scott White will be presenting the benefits of printed programmable logic in the main conference at 15:40 on December 3rd.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.